Printed from https://fyi.org.nz/similar/request/7999-dexrazoxane-nppa-approval?page=3 on June 17, 2026 13:17

Requests similar to 'dexrazoxane NPPA Approval' (page 3)

Pandemic Vaccine Procurement, India FTA Implications, and Advance Purchase Agreement Framework
Response by Pharmaceutical Management Agency to Penny Claridge on .
Awaiting response.
Thank you for contacting Pharmac. We have received your enquiry and will respond as soon as possible. Pharmac cannot provide medical advice. If you...
Correspondence
Response by Auckland University of Technology to Eddy on .
Awaiting classification.
Dear Eddy Please find attached information in response to your request below.   Regards Alison       [1]AUTMaori Alison Sykora   She/her...
Wanaka Hatchery Site
Response by Otago Fish and Game Council to J Smith on .
Awaiting classification.
Dear Mr Smith   I refer to your Official Information Act correspondence dated 15^th February 2021    1. I can now confirm that I have not prev...
Trikafta Funding Announcement
Response by Pharmaceutical Management Agency to Phillip Hart on .
Partially successful.
Tçnâ koe Phillip   Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta...
Management of Dexamfetamine supply
Response by Pharmaceutical Management Agency to Anita Easton on .
Partially successful.
Dear Anita   Please find attached PHARMAC’s response to your recent OIA request.   Kind regards Victoria London PHARMAC       15 Feb...
Documentation on Whakatohea 2017 to present
Response by Office of Treaty Settlements and Takutai Moana—Te Tari Whakatau to Tim Herewini on .
Awaiting classification.
Tçnâ koe   Just sending through a final follow up in regards to our response to the request. See attached.   If you have a response please get...
Decision not to provide information to Today FM or Mediaworks
Response by Pharmaceutical Management Agency to New Zealand Council for Civil Liberties on .
Refused.
Tēnā koe   Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta consul...
The total legal costs incurred by Pharmac in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health: common bundle
Response by Pharmaceutical Management Agency to John Armstrong on .
Successful.
Kia ora John   Please find attached a response to your request for official information.   Ngâ mihi,   Government Services | Pharmac ____...
Missed time from work considered?
Response by Pharmaceutical Management Agency to PCBS on .
Successful.
Kia ora Paul   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac 2 Jul...
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison, PHARMAC is extending the response date for your request, please see letter attached. Please let me know if you have any questions o...
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs,   Thank you for your request for official information, received by PHARMAC on 23 April 2020.   Your request has been received and l...
Treatment of inflammatory bowel disease by biologics
Response by Ministry of Health to John Mayberry on .
Awaiting classification.
Kia ora John,   I am Sean from the data services team at the Ministry of Health, and I will do my best to help with this query. We are the team...
Decision to delay Pump and CGM Funding for T1 Diabetics
Response by David Seymour to Fiona Smith on .
Awaiting classification.
Dear Fiona Thank you for your email in which you submitted an Official Information Act request as follows: "Please provide under the Official Informa...
Immunosuppressed/diabetic/cancer populations - common associated conditions.
Response by Pharmaceutical Management Agency to J Bruning on .
Information not held.
Kia ora Jodie, Please find attached a response to your Official Information Act request of 17 April 2024. Thank you Government Services _____________...
Citation list for PHARMAC funded thyroid medications and patient survey data
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Dear Belinda Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...
Availability and funding of WHO Essential Medicines
Response by Pharmaceutical Management Agency to Laydan Mortensen on .
Information not held.
Dear Laydan This email is to acknowledge that your request for information under the Official Information Act (1982) has been received and is currentl...
People using PrEP contracting HIV
Response by Pharmaceutical Management Agency to The Magic Roast on .
Partially successful.
Hi Jacky, huge apologies! Here is our response. Have a lovely weekend Jane Jacky Thorndon [FOI #9905 email] 26 April 2019 Dear Jacky, REQUEST FOR I...
Covid advisory group minutes from 2022 to present
Response by Health New Zealand to Al on .
Successful.
Kia ora Al, Please find attached a response to the remaining parts of your request. Ngā mihi     OIA Services Team Manatū Hauora | Ministry of...
Under 40s - extent of co-prescribing for ADHD, anxiety, depression.
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora Jodie,   Please find attached a response to your Official Information Act request, which was received on 2 October 2024.   Please cont...
Numbers of prescriptions: Antidepressants Antipsychotics and ADHD medication/stimulants
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J Bruning   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac...
Comirnaty (JN.1) vaccine
Response by Pharmaceutical Management Agency to Catherine Jamieson on .
Successful.
Kia ora Catherine   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac...
Legal costs in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health
Response by Pharmaceutical Management Agency to John Armstrong on .
Refused.
Kia ora John,   Thank you for your email.   We have interpreted your question below as enquiring about the financial impact on Pharmac of disclosi...
Kostaive self-amplifying mRNA in New Zealand
Response by Pharmaceutical Management Agency to John Armstrong on .
Successful.
Kia ora John Please find attached a response to your request for official information. Ngā mihi, Government Services | Pharmac 09 December 2025 John...
Heritage status Wellington railway station - GoMedia
Response by Wellington Regional Council to Carl Wiggin on .
Successful.
Tēnā koe Carl Request for information 2023-170 I refer to your request for information dated 26 June 2023, which was received by Greater Wellingto...
Trikafta "27 more years at full health" claim.
Response by Pharmaceutical Management Agency to Laydan Mortensen on .
Successful.
Kia ora Laydan Please find attached a response to your request for official information. Ngâ mihi, Government Services | Pharmac ___________________...